" /> Anti-DLL3 ADC ZL-1310 - CISMeF





Preferred Label : Anti-DLL3 ADC ZL-1310;

NCIt synonyms : ADC SC-002; Anti-DLL3 Antibody-drug Conjugate ZL-1310;

NCIt definition : An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) and linked to an as of yet unelucidated cytotoxic agent, with potential immunostimulating and antineoplastic activities. Upon administration, anti-DLL3 ADC ZL-1310 targets and binds to DLL3 found on DLL3-expressing tumor cells. Upon internalization, the cytotoxic agent causes cell death in DLL3-expressing tumor cells through an as of yet unknown mechanism of action. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.;

Molecule name : YL 212; ZL-1310; YL-212; ZL 1310;

NCI Metathesaurus CUI : CL1922422;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.